Concepedia

Publication | Open Access

Randomized, Double-Blind Study Comparing Proposed Biosimilar La-Ep2006 with Reference Pegfilgrastim in Breast Cancer

37

Citations

10

References

2016

Year

Abstract

LA-EP2006 and reference pegfilgrastim showed no clinically meaningful differences regarding efficacy and safety in breast cancer patients receiving chemotherapy.

References

YearCitations

Page 1